Becton Dickinson & Company recalls 13 Fr. Trialysis Catheter with Alphacurve. Catalog No. 5653150. UDI: 00801741066023 Power-Trialysis Short-Term Alphacur…
- Recall date
- September 16, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0285-2020
- FDA classification
- Class II
- Brand / firm
- Becton Dickinson & Company
- Sold / distributed
- Distributed to healthcare facilities in AR, FL, IL, NJ, TX, and WI.
Why it was recalled
A portion of the lot was incorrectly packaged with a 12.5cm catheter instead of a 15cm catheter.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
13 Fr. Trialysis Catheter with Alphacurve. Catalog No. 5653150. UDI: 00801741066023 Power-Trialysis Short-Term Alphacurve Dialysis Catheter with a third internal umen for IV therapy, power injection of contrast media, and central venous pressure monitoring.
Get recall alerts
Free email alert whenever Becton Dickinson & Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Becton Dickinson & Company